Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins

被引:39
作者
Clay, MA
Pyle, DH
Rye, KA
Vadas, MA
Gamble, JR
Barter, PJ
机构
[1] Univ Adelaide, Dept Med, Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[2] Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia
[3] Royal Adelaide Hosp, Cardiovasc Invest Unit, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
reconstituted HDL; endothelial cells; VCAM-1; time sequence;
D O I
10.1016/S0021-9150(00)00659-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have used discoidal reconstituted high density lipoproteins (rHDL) containing apolipoprotein (apo) A-I and dimyristoyl phosphatidylcholine (DMPC) as a tool to investigate the time sequence of the HDL-mediated inhibition of vascular cell adhesion molecule (VCAM)-1 and E-selectin expression in cytokine-activated human umbilical vein endothelial cells (HUVECs). Specifically, we have asked a few questions-(i) how long do the cells need to be exposed to the rHDL before adhesion molecule expression is inhibited and (ii) how long does the inhibition persist after removing the rHDL from the cells. When the cells were not pre-incubated with the rHDL, there was no inhibition. The magnitude of the inhibition increased progressively with increasing duration of pre-incubation up to 16 h. Inhibition did not require the rHDL to be physically present during the activation of adhesion molecule expression by tumour necrosis factor(TNF)-alpha, excluding the possibility that the rHDL was merely interfering with the interaction between TNF-alpha and the cells. When HUVECs were pre-incubated for 16 h with rHDL, the inhibition remained substantial even if the rHDL were removed from the medium up to 8 h prior to addition of TNF-a. The HDL-mediated inhibition of VCAM-1 in HUVECs was unaffected by the presence of puromycin, an inhibitor of protein synthesis, excluding the possibility that HDL may have acted by stimulating the synthesis of a cell protein that itself inhibits adhesion molecule expression. These results have important implications in terms of understanding the mechanism(s) of the HDL-mediated inhibition of endothelial adhesion molecule expression. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 27 条
  • [1] Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells
    Ashby, DT
    Rye, KA
    Clay, MA
    Vadas, MA
    Gamble, JR
    Barter, PJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) : 1450 - 1455
  • [2] Baker PW, 1999, J LIPID RES, V40, P345
  • [3] Baker PW, 2000, J LIPID RES, V41, P1261
  • [4] Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins
    Calabresi, L
    Franceschini, G
    Sirtori, CR
    DePalma, A
    Saresella, M
    Ferrante, P
    Taramelli, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (01) : 61 - 65
  • [5] Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II
    Clay, MA
    Cehic, DA
    Pyle, DH
    Rye, KA
    Barter, PJ
    [J]. BIOCHEMICAL JOURNAL, 1999, 337 : 445 - 451
  • [6] HIGH-DENSITY-LIPOPROTEINS INHIBIT CYTOKINE-INDUCED EXPRESSION OF ENDOTHELIAL-CELL ADHESION MOLECULES
    COCKERILL, GW
    RYE, KA
    GAMBLE, JR
    VADAS, MA
    BARTER, PJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) : 1987 - 1994
  • [7] Cockerill GW, 1999, CIRCULATION, V100, P813
  • [8] Apo A-I inhibits foam cell formation in apo E-deficient mice after monocyte adherence to endothelium
    Dansky, HM
    Charlton, SA
    Barlow, CB
    Tamminen, M
    Smith, JD
    Frank, JS
    Breslow, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) : 31 - 39
  • [9] Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice
    Dimayuga, P
    Zhu, J
    Oguchi, S
    Chyu, KY
    Xu, XOH
    Yano, J
    Shah, PK
    Nilsson, J
    Cercek, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (02) : 465 - 468
  • [10] FIELDING CJ, 1995, J LIPID RES, V36, P211